Arch Venture Fund X, L.p.

Affiliations

  • Large Shareholder at Maze Therapeutics Inc. (MAZE), 2025-01-30
  • Large Shareholder at Prime Medicine Inc. (PRME), 2024-02-20
  • Large Shareholder at Sana Biotechnology Inc. (SANA), 2024-02-12
  • Large Shareholder at Neumora Therapeutics Inc. (NMRA), 2023-12-13
  • Large Shareholder at Erasca Inc. (ERAS), 2021-07-21
  • Large Shareholder at Verve Therapeutics Inc. (VERV), 2021-06-23
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SANA $5.50 727,272 $3,999,996.00 12,446,022 2024-02-08 Filing
SANA $5.50 727,272 $3,999,996.00 12,446,022 2024-02-08 Filing
SANA $5.50 363,637 $2,000,003.50 10,667,387 2024-02-08 Filing